Rapid molecular confirmation of infectious disease

DiaSorin has strengthened its range of infectious disease diagnostic assays for maternal and neonatal health with the launch of Iam HSV for use with the DiaSorin Liaison Iam analyser.

The launch of this new molecular assay provides rapid and reliable differential detection of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in human cerebrospinal fluid (CSF), vesicle swabs, plasma and whole blood. Together with Iam VZV for the detection of clinically relevant subtypes of varicella zoster virus (VZV), these assays allow the rapid and reliable detection of alphaherpesvirus infections in pregnant women and neonates.

Nucleic acid tests are the methods of choice for the diagnosis and characterisation of HSV infection, following baseline serology, offering greater sensitivity than viral culture. In addition, the ability to differentiate between HSV types can provide important prognostic information, particularly in the diagnosis of genital herpes. Active maternal HSV infection can be diagnosed from swab specimens while neonatal infection is commonly diagnosed from CSF and whole blood.
www.diasorin.com

 

Other news

Learning from history

Upcoming Events

Lab Innovations

NEC, Birmingham (Hall 12)
30-31 October 2019

British Society for Immunology Congress

Arena and Convention Centre, Kings Dock, Liverpool Waterfront, Liverpool L3 4FP
2-5 December 2019

The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

RAF Museum, Hendon, London
14 May 2020

Clinical and Laboratory Haemostasis 2020

STEM/Atrium Conference Centre, Sheffield Hallam University
3-4 June 2020

Latest Issue

Pathology In Practice

Pathology In Practice

Oct 2019

Are you ready for the winter influenza season?

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.